Price Chart

Profile

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.
URL http://www.assertiotx.com
Investor Relations URL https://investor.assertiotx.com/overview/default.aspx
HQ State/Province Illinois
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release Mar. 09, 2026 (est.)
Last Earnings Release Nov. 10, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.
URL http://www.assertiotx.com
Investor Relations URL https://investor.assertiotx.com/overview/default.aspx
HQ State/Province Illinois
Sector Health Care
Industry Pharmaceuticals
Next Earnings Release Mar. 09, 2026 (est.)
Last Earnings Release Nov. 10, 2025
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A